Showing results (1551-1560 of 1,714) with videos related to
Sort By:
Pageof 172
Frontiers in Immunology|September 15, 2023
Changes in subcutaneous white adipose tissue cellular composition and molecular programs underlie glucose intolerance in persons with HIVSamuel S Bailin, Jonathan A Kropski, Rama D Gangula, et al.Cardiology|February 28, 2009
Distal left main coronary bifurcation lesions predict worse outcome in patients undergoing percutaneous implantation of drug-eluting stents: results from the Drug-Eluting Stent for the Treatment of Left Main Disease (DISTAL) StudyShao-Liang Chen, Fei Ye, Jun-jie Zhang, et al.Cancer Immunology Research|April 12, 2017
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced MelanomaDaniel Y Wang, Zeynep Eroglu, Alpaslan Ozgun, et al.Scientific Reports|March 11, 2025
Study on the potential clinical significance of subclinical stent edge effects after drug-eluting stent implantationYi Xu, Yi-Fei Wang, Meng-Yao Zhao, et al.Journal of Medicinal Chemistry|October 12, 2017
Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell ProliferationChen Wang, Hao Jiang, Jia Jin, et al.Cancer Research|September 13, 2011
A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancerEmily M Fox, Todd W Miller, Justin M Balko, et al.The Journal of Clinical Investigation|April 10, 2014
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLCKatherine R Amato, Shan Wang, Andrew K Hastings, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 7, 2020
Mutations of RNF213 are responsible for sporadic cerebral cavernous malformation and lead to a mulberry-like cluster in zebrafishJing Lin, Jie Liang, Jun Wen, et al.Cell Reports|July 15, 2023
Spermine is a natural suppressor of AR signaling in castration-resistant prostate cancerXiao Li, Fei Li, Fei Ye, et al.Cancer Research|January 9, 2016
EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung CancerKatherine R Amato, Shan Wang, Li Tan, et al.Pageof 172